Nature: Safety trials of Ebola vaccines are starting to return results: at least one is known to be safe and to summon an immune response against the virus. The challenge now is to use the results to guide the larger studies that will reveal whether the vaccines work.
BBC World Service: Professor Ellie Barnes, Jenner Investigator and leader of the Hepatitis C vaccine programme at the University of Oxford, talks to Jack Stewart, 'Science in Action'.
CNN: Adrian Hill of Oxford University, the lead trial researcher on an Ebola vaccine, speaks with Christiane Amanpour.
The Guardian: A woman in Oxford has become the first British volunteer to be injected with an experimental Ebola vaccine, which, if it works, will be fast-tracked for use in west Africa.
BBC: The first healthy volunteer has received an experimental Ebola vaccine in Oxford.
Press release: Oxford University’s Jenner Institute is to start clinical safety tests of a candidate Ebola vaccine, aimed at preventing the disease that has killed more than 1,200 people in the current outbreak in West Africa.
Helen McShane, BSc MBBS PhD London, Faculty of Clinical Medicine, has been voted onto Oxford University Council. From September, she will represent two Divisions: Medical Sciences (MedSci) and Mathematical, Physical and Life Sciences (MPLS). This is a prestigious post which will put one of ...
Press release: A novel malaria vaccine developed at Oxford University has shown promising results in the first clinical trial to test whether it can protect people against the mosquito-borne disease.
BBC Radio 4: HIV has been one of modern medicine's most implacable foes. Thirty one years since AIDS was first observed in the west with 30m deaths worldwide since, it has been tamed but not beaten.
CBS: An experimental malaria vaccine once thought promising is turning out to be a disappointment, with a new study showing it is only about 30 percent effective at protecting infants from the killer disease.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.